Viewing Study NCT06587997



Ignite Creation Date: 2024-10-26 @ 3:39 PM
Last Modification Date: 2024-10-26 @ 3:39 PM
Study NCT ID: NCT06587997
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-05

Brief Title: Changes in Renal Perfusion During Hemodialysis in Patients with End-stage Renal Disease
Sponsor: None
Organization: None

Study Overview

Official Title: Changes in Renal Perfusion During Hemodialysis in Patients with End-stage Renal Disease a Prospective Observational Study
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HD-RPC
Brief Summary: Residual renal function RRF characteristically declines after patients with end-stage renal disease ESRD initiate dialysis Although RRF preservation correlates with improved patientamp39s quality of life and survival prospects poor understanding of the pathophysiology underlying RRF decline limits protection strategies
Detailed Description: Hemodialysis HD is the primary renal replacement therapy for patients with end-stage renal disease However residual renal function RRF characteristically declines after these individuals start dialysis This loss of RRF not only impacts the adequacy of dialysis and control of complications but also affects the patientamp39s quality of life and survival prospects Due to a lack of clear understanding regarding the pathophysiology underlying this decline in RRF no effective strategies exist for its preservation at present The objective of this study is to explore the changes in renal perfusion during hemodialysis in patients with end-stage renal disease and provide a new idea for protection of RRF This study was an observational study and no interventions were performed

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None